Ning Li

I specialise in rare tumours such as lung cancer, thymic tumours, malignant mesothelioma, soft tissue sarcoma, small bowel tumours, malignant neurofibroma, neuroendocrine carcinoma and adrenal cortical carcinoma. I am the first to adopt precise molecular diagnosis for each patient, and individualize the appropriate new methods such as targeted, cellular, antibody, and cancer vaccine to treat patients with refractory, or relapsed tumors, which has gained international recognition. Ning Li, M.D. Vice president, National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences, & Peking Union Medical College, State Key Laboratory of Molecular Oncology Director, Office of National Cancer Center of China; Assistant President, Cancer Hospital, CAMS Director, Department of Clinical Trial Center President, National Cancer Hospital, Hebei Chinese Academy of Medical Sciences Chief physician & Professor, Thoracic Surgery department, Cancer Hospital, CAMS Inspector of National Medical Products Administration of China